ASSEMBLY BIOSCIENCES, INC. — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ab387b8d-4691-41c4-834b-1e412ae7aabe/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-12.1M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-115992 |
| FY 2024 | $-45.4M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-042673 |
| FY 2023 | $-64.6M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-038057 |
| FY 2022 | $-94.1M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-009184 |
| FY 2021 | $-132.7M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-009855 |
| FY 2020 | $-64.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008878 |
| FY 2019 | $-102.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-008696 |
| FY 2018 | $-92.7M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-011361 |
| FY 2017 | $-52.2M | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-011361 |
| FY 2016 | $-45.3M | 2016-01-01 – 2016-12-31 | evidence 0001144204-19-011361 |
| FY 2015 | $-29.7M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-087539 |
| FY 2014 | $-24.0M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-015700 |
| FY 2013 | $-102.3M | 2005-10-07 – 2014-03-31 | evidence 0001144204-14-030423 |
| FY 2012 | $-82.4M | 2005-10-07 – 2013-03-31 | evidence 0001144204-13-027924 |
| FY 2011 | $-62.0M | 2005-10-07 – 2012-03-31 | evidence 0001144204-12-027148 |
| FY 2010 | $-4.8M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-014863 |
| FY 2009 | $-3.3M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-014863 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ASSEMBLY BIOSCIENCES, INC. — all facts · Revenue · Net Income